# Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation

Study · id `cardio:ct-nct07926854` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07926854](<https://clinicaltrials.gov/study/NCT07926854>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07926854

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 294 participants.

## Technical summary

Registry record NCT07926854. Randomized; single masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 294 participants (planned count; ClinicalTrials.gov record NCT07926854, source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)
- Planned start: 2026-11 (anticipated) (ClinicalTrials.gov record NCT07926854, source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07926854, source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT07926854, source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT07926854, source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07926854-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Unipolar Voltage-Guided Substrate Modification Plus Pulsed Field Ablation Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone in Persistent Atrial Fibrillation
- Acronym: UNI-PFA
- Condition: Atrial Fibrillation (AF)
- Intervention (Device): VARIPULSE Pulsed Field Ablation System
- Intervention (Procedure): Pulmonary Vein Isolation
- Intervention (Procedure): Individualized Substrate Modification
- Lead sponsor: China National Center for Cardiovascular Diseases
- Lead sponsor class: OTHER\_GOV
- Collaborator: Sir Run Run Shaw Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: Affiliated Hospital of Hebei University
- Collaborator class: OTHER
- Collaborator: Shanxi Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: The University of Hong Kong-Shenzhen Hospital
- Collaborator class: OTHER
- Collaborator: The Second Hospital of Hebei Medical University
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Xi'an Jiaotong University
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: China National Center for Cardiovascular Diseases (`cardio:org-china-national-center-for-cardiovascular-diseases`)
- Registry lists this organization as a collaborator: Sir Run Run Shaw Hospital (`cardio:org-sir-run-run-shaw-hospital`)
- Registry lists this organization as a collaborator: Guangdong Provincial People's Hospital (`cardio:org-guangdong-provincial-people-s-hospital`)
- Registry lists this organization as a collaborator: Shanxi Cardiovascular Hospital (`cardio:org-shanxi-cardiovascular-hospital`)
- Registry lists this organization as a collaborator: The Second Hospital of Hebei Medical University (`cardio:org-the-second-hospital-of-hebei-medical-university`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital of Xi'an Jiaotong University (`cardio:org-second-affiliated-hospital-of-xi-an-jiaotong-university`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Chongqing Medical University (`cardio:org-the-second-affiliated-hospital-of-chongqing-medical-739711`)

## Provenance

Content hash: 2e951458e0ae20e7b967533f699acf93972fb8ac6240aba7028bde0283647f0c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
